医药制造业是关系到国计民生的基础性产业,目前我国已经形成包括化学药品制造、中药材及中成药加工、生物制品、化学原料药制造、化学药品制剂等门类齐全的产业体系。2017年,是实施“十三五”规划的重要一年,是供给侧结构性改革的深化之年,也是医药行业改革的关键一年。这一年,河南省进一步深化推进医药卫生体制改革,将“控费”作为全年卫生工作重点之一。发展中药饮片、中成药成“业务骨干”,立根固本,不断寻求新的收入增长点,促进营销渠道呈现多样化。保持了平稳发展态势,为河南医药行业做大、做强奠定了良好的基础。
<<The pharmaceutical manufacturing industry is a basic industry related to the national economy and the people’s livelihood. At present,China has formed a complete industrial system including the manufacture of chemical drugs,the processing of Chinese medicinal materials and Chinese patent medicines,the manufacture of biological products,chemical raw materials,chemical drugs and so on. In 2017,it is an important year for the implementation of the 13th Five-Year plan. It is the deepening year of the supply side structural reform,and also the key year for the reform of the pharmaceutical industry. This year,Henan further deepened the reform of the medical and health system,and controlled the fee as one of the priorities of the annual health work. Henan develops the Chinese herbal medicine and Chinese patent medicine into a “business backbone”,consolidating its roots and constantly seeking new revenue growth points,and promoting diversification of marketing channels. It maintained a steady development trend and laid a good foundation for Henan pharmaceutical industry to become bigger and stronger.
<<